D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 120 Citations 45,521 713 World Ranking 2127 National Ranking 1233

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Radiation therapy

His primary areas of investigation include Radiation therapy, Prostate cancer, Surgery, Prostate and Cancer. Michael J. Zelefsky has researched Radiation therapy in several fields, including Stage, Nuclear medicine and Urology. Prostate cancer is a subfield of Internal medicine that he studies.

The concepts of his Internal medicine study are interwoven with issues in Oncology and Physician visit. His work deals with themes such as Carcinoma and Toxicity, which intersect with Surgery. Michael J. Zelefsky interconnects Brachytherapy, Rectum, Biopsy, Pathology and Complication in the investigation of issues within Prostate.

His most cited work include:

  • Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. (854 citations)
  • High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients (723 citations)
  • Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy (712 citations)

What are the main themes of his work throughout his whole career to date?

Michael J. Zelefsky spends much of his time researching Prostate cancer, Radiation therapy, Internal medicine, Oncology and Surgery. His Prostate cancer study integrates concerns from other disciplines, such as Radiology, Prostate, Brachytherapy and Urology. His Prostate study incorporates themes from Rectum, Biopsy and Nuclear medicine.

His work investigates the relationship between Radiation therapy and topics such as Cancer that intersect with problems in Cohort. His Oncology research is multidisciplinary, incorporating elements of Conformal radiotherapy and External beam radiation. Michael J. Zelefsky frequently studies issues relating to Carcinoma and Surgery.

He most often published in these fields:

  • Prostate cancer (51.58%)
  • Radiation therapy (44.84%)
  • Internal medicine (37.39%)

What were the highlights of his more recent work (between 2013-2021)?

  • Prostate cancer (51.58%)
  • Radiation therapy (44.84%)
  • Oncology (35.53%)

In recent papers he was focusing on the following fields of study:

Michael J. Zelefsky mainly investigates Prostate cancer, Radiation therapy, Oncology, Internal medicine and Prostate. The Prostate cancer study combines topics in areas such as Radiology, Brachytherapy and Urology. His Radiation therapy study is concerned with the field of Surgery as a whole.

His research in Oncology intersects with topics in Prostatectomy, Biochemical recurrence, Metastasis, Disease and Hazard ratio. In general Internal medicine, his work in Randomized controlled trial, Very high risk, Biomarker and Bladder cancer is often linked to Term linking many areas of study. His Prostate research also works with subjects such as

  • Fiducial marker most often made with reference to Nuclear medicine,
  • Rectum which is related to area like Dosimetry.

Between 2013 and 2021, his most popular works were:

  • A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score. (697 citations)
  • American Cancer Society prostate cancer survivorship care guidelines (223 citations)
  • Early Salvage Radiotherapy Following Radical Prostatectomy (125 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Radiation therapy

The scientist’s investigation covers issues in Prostate cancer, Radiation therapy, Prostate, Radiology and Surgery. His Prostate cancer research includes themes of Oncology and Urology. His studies in Radiation therapy integrate themes in fields like Cancer, Multivariate analysis, Retrospective cohort study, Prostate-specific antigen and Cohort.

His work carried out in the field of Prostate brings together such families of science as Dose fractionation, Urinary system, Nuclear medicine and Urethra. Michael J. Zelefsky has included themes like Laryngeal Neoplasm and Carcinoma in his Radiology study. The various areas that Michael J. Zelefsky examines in his Surgery study include Prostatectomy and Sexual function.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.

Jonathan I. Epstein;Michael J. Zelefsky;Daniel D. Sjoberg;Joel B. Nelson.
European Urology (2016)

1247 Citations

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

Michael J. Zelefsky;Steven A. Leibel;Paul Gaudin;Gerald J. Kutcher.
International Journal of Radiation Oncology Biology Physics (1998)

1210 Citations

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients

Michael J Zelefsky;Zvi Fuks;Margie Hunt;Yoshiya Yamada.
International Journal of Radiation Oncology Biology Physics (2002)

1006 Citations

HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED PROSTATE CANCER

Michael J. Zelefsky;Zvi Fuks;Margie Hunt;Henry J. Lee.
The Journal of Urology (2001)

991 Citations

Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy

Andrew J. Stephenson;Peter T. Scardino;Michael W. Kattan;Thomas M. Pisansky.
Journal of Clinical Oncology (2007)

988 Citations

DOSE ESCALATION WITH THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY AFFECTS THE OUTCOME IN PROSTATE CANCER

M.J. Zelefsky;S.A. Leibel;P.B. Gaudin;G.J. Kutcher.
The Journal of Urology (1999)

943 Citations

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate Cancer

Michael J. Zelefsky;Emily J. Levin;Margie Hunt;Yoshiya Yamada.
International Journal of Radiation Oncology Biology Physics (2008)

804 Citations

Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer.

Michael J Zelefsky;Zvi Fuks;Laura Happersett;Henry J Lee.
Radiotherapy and Oncology (2000)

762 Citations

Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy

Andrew J. Stephenson;Shahrokh F. Shariat;Michael J. Zelefsky;Michael W. Kattan.
JAMA (2004)

736 Citations

Fluoroscopically Guided Interventional Procedures: A Review of Radiation Effects on Patients’ Skin and Hair

Stephen Balter;John W. Hopewell;Donald L. Miller;Louis K. Wagner.
Radiology (2010)

641 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Michael J. Zelefsky

Anthony V. D'Amico

Anthony V. D'Amico

Brigham and Women's Hospital

Publications: 134

Nancy Y. Lee

Nancy Y. Lee

Memorial Sloan Kettering Cancer Center

Publications: 122

Paul L. Nguyen

Paul L. Nguyen

Harvard Medical School

Publications: 121

Mack Roach

Mack Roach

University of California, San Francisco

Publications: 117

Howard M. Sandler

Howard M. Sandler

Cedars-Sinai Medical Center

Publications: 108

Alan Pollack

Alan Pollack

University of Miami

Publications: 100

Eric M. Horwitz

Eric M. Horwitz

Fox Chase Cancer Center

Publications: 100

Richard G. Stock

Richard G. Stock

Icahn School of Medicine at Mount Sinai

Publications: 99

David P. Dearnaley

David P. Dearnaley

Institute of Cancer Research

Publications: 95

Hashim U. Ahmed

Hashim U. Ahmed

Imperial College Healthcare NHS Trust

Publications: 90

Michael W. Kattan

Michael W. Kattan

Cleveland Clinic

Publications: 90

Roberto Orecchia

Roberto Orecchia

European Institute of Oncology

Publications: 89

Mark H. Bilsky

Mark H. Bilsky

Memorial Sloan Kettering Cancer Center

Publications: 84

Deborah A. Kuban

Deborah A. Kuban

The University of Texas MD Anderson Cancer Center

Publications: 84

Peter T. Scardino

Peter T. Scardino

Memorial Sloan Kettering Cancer Center

Publications: 79

Eric A. Klein

Eric A. Klein

Cleveland Clinic

Publications: 77

Trending Scientists

Benoit Baudry

Benoit Baudry

Royal Institute of Technology

Fisher Yu

Fisher Yu

ETH Zurich

Vivekananda Mukherjee

Vivekananda Mukherjee

Indian Institute of Technology Dhanbad

Lynne S. Taylor

Lynne S. Taylor

Purdue University West Lafayette

Motomasa Kobayashi

Motomasa Kobayashi

Osaka University

Shahram Tangestaninejad

Shahram Tangestaninejad

University of Isfahan

Jing Sun

Jing Sun

Chinese Academy of Sciences

Alexei Gruverman

Alexei Gruverman

University of Nebraska–Lincoln

Weiwei Gao

Weiwei Gao

University of California, San Diego

David Pearce

David Pearce

Northumbria University

Edward D. Goldberg

Edward D. Goldberg

Scripps Institution of Oceanography

Joanna Joiner

Joanna Joiner

Goddard Space Flight Center

Francine M. Benes

Francine M. Benes

Harvard University

Martin Brüne

Martin Brüne

Ruhr University Bochum

Brigitte Dreno

Brigitte Dreno

University of Nantes

Nancy Edwards

Nancy Edwards

University of Ottawa

Something went wrong. Please try again later.